Rubicon Research Overview
- Year Founded
-
1999
- Status
-
Public
- Employees
-
1,885
- Stock Symbol
-
RUBICON
- Investments
-
7
- Share Price
-
$18.33
- (As of Thursday Closing)
Rubicon Research General Information
Description
Rubicon Research Ltd is a pharmaceutical formulations company specializing in developing, manufacturing, and marketing branded specialty and generic prescription products. Starting as a provider of contract formulation development services, the company expanded to operate an oral solids manufacturing facility in India, offering contract development and manufacturing services for regulated markets. The company's diverse product portfolio covers multiple therapeutic areas, including analgesics and pain management, CVS, CNS, hypokalemia, skeletal muscle relaxants, NRT, gastrointestinal, metabolic, and immunosuppressants. The company operates in India, the USA, and other markets, with the majority of its revenue coming from the USA.
Contact Information
Website
www.rubicon.co.inCorporate Office
- MedOne House, Plot Number B-75
- Road Number 33, Wagle Estate
- Thane, Maharashtra 400604
- India
Corporate Office
- MedOne House, Plot Number B-75
- Road Number 33, Wagle Estate
- Thane, Maharashtra 400604
- India
Rubicon Research Stock Performance
As of 12-Nov-2026, Rubicon Research’s stock price is $18.33. Its current market cap is $3.03B with 166M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $18.33 | $18.34 | $6.76 - $19.89 | $3.03B | 166M | 310K | $0.21 |
Rubicon Research Financials Summary
As of 30-Sep-2026, Rubicon Research has a trailing 12-month revenue of $227M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 2,788,204 | 1,384,246 | ||
| Revenue | 226,509 | 195,914 | 149,852 | 101,803 |
| EBITDA | 55,479 | 44,106 | 31,253 | 20,513 |
| Net Income | 35,035 | 27,923 | 15,890 | 10,994 |
| Total Assets | 287,431 | 246,598 | 169,680 | 133,043 |
| Total Debt | 52,187 | 32,962 | 50,821 | 52,904 |
Rubicon Research Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Rubicon Research Comparisons
Industry
Financing
Details
Rubicon Research Competitors (5)
One of Rubicon Research’s 5 competitors is La Chandra Pharmalab Private, a Corporation company based in Ahmedabad, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| La Chandra Pharmalab Private | Corporation | Ahmedabad, India | ||||
| Megafine Pharma | Private Equity-Backed | Mumbai, India | ||||
| Vasudha Pharma | Corporation | Hyderabad, India | ||||
| Jigs Chemical | Corporation | Ahmedabad, India | ||||
| Symed Labs | Formerly PE-Backed | Hyderabad, India |
Rubicon Research Patents
Rubicon Research Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250057789-A1 | Stable oral liquid formulations containing metoprolol or salts thereof | Pending | 20-Aug-2023 | ||
| WO-2025041166-A1 | Stable oral liquid formulations containing metoprolol or salts thereof | Inactive | 20-Aug-2023 | ||
| US-20240390277-A1 | Liquid formulations of trazodone | Pending | 15-Apr-2023 | ||
| WO-2024220372-A1 | Liquid formulations of trazodone | Inactive | 15-Apr-2023 | ||
| WO-2022123607-A1 | Pharmaceutical formulations of esketamine | Inactive | 10-Dec-2020 | A61K9/0043 |
Rubicon Research Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Rubicon Research Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Rubicon Research Investments & Acquisitions (7)
Rubicon Research’s most recent deal was a Merger/Acquisition with Arinna Lifesciences for . The deal was made on 30-Apr-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Arinna Lifesciences | 30-Apr-2026 | Merger/Acquisition | Pharmaceuticals | ||
| Neuronasal | 27-Oct-2025 | Corporate | Drug Discovery | ||
| Alkem Laboratories (Manufacturing Facility In Pithampur) | 24-Jun-2025 | Buyout/LBO | Buildings and Property | ||
| AIM Rx (Warehousing Facility in United States) | 01-Jan-2025 | Buyout/LBO | Buildings and Property | ||
| Validus Pharmaceuticals | 01-Feb-2024 | Buyout/LBO | Pharmaceuticals |
Rubicon Research ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Rubicon Research Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| AdvaGen Pharma | Plainsboro, NJ | 2017 | |
| Arinna Lifesciences | Ahmedabad, India | 2013 | |
| Validus Pharmaceuticals | East Brunswick, NJ | 2007 |
Rubicon Research FAQs
-
When was Rubicon Research founded?
Rubicon Research was founded in 1999.
-
Where is Rubicon Research headquartered?
Rubicon Research is headquartered in Thane, India.
-
What is the size of Rubicon Research?
Rubicon Research has 1,885 total employees.
-
What industry is Rubicon Research in?
Rubicon Research’s primary industry is Drug Discovery.
-
Is Rubicon Research a private or public company?
Rubicon Research is a Public company.
-
What is Rubicon Research’s stock symbol?
The ticker symbol for Rubicon Research is RUBICON.
-
What is the current stock price of Rubicon Research?
As of 12-Nov-2026 the stock price of Rubicon Research is $18.33.
-
What is the current market cap of Rubicon Research?
The current market capitalization of Rubicon Research is $3.03B.
-
What is Rubicon Research’s current revenue?
The trailing twelve month revenue for Rubicon Research is $227M.
-
Who are Rubicon Research’s competitors?
La Chandra Pharmalab Private, Megafine Pharma, Vasudha Pharma, Jigs Chemical, and Symed Labs are competitors of Rubicon Research.
-
What is Rubicon Research’s annual earnings per share (EPS)?
Rubicon Research’s EPS for 12 months was $0.21.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
